Pure Global
NCT06308666

Performance of DAILIES TOTAL1 Daily Disposable Contact Lenses in Habitual Soft Lens Wearers Who Report Substantial Digital Device Use

University of Waterloo·ClinicalTrials.gov·device·Device trialRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Myopia
Drug/Device/Intervention
Delefilcon A contact lenses
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
University of Waterloo
Location
Waterloo, Canada
Timeline & enrollment
Phase
N/A
Start date
Mar 18, 2024
End date
Jul 18, 2024
Enrollment
35 participants
Primary outcome

Subjective Rating of Comfort After 8 Hours or More of Digital Device Use,Subjective Rating of Dryness After 8 Hours or More of Digital Device Use,Subjective Rating of Clarity of Vision After 8 Hours or More of Digital Device Use

Summary

The purpose of this study is to evaluate the performance of DAILIES TOTAL1 daily disposable
 contact lenses with regards to subjective symptoms (comfort, dryness, vision) in lens wearers
 who use identify themselves as substantial digital device users (at least eight hours of
 digital device use per day).

ICD-10 classifications
MyopiaDegenerative myopiaAmblyopia ex anopsiaOcular myiasisMyiasis
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06308666
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06308666 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Waterloo and is currently Recruiting. The study focuses on Myopia. Target enrollment is 35 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.